Posts tagged ‘alzheimer's disease’

This installment was written by QPS, a global leader in clinical and preclinical research. Drug development for the treatment of neurodegenerative...

With the increasing need for effective drug development for chronic diseases, collaborations and partnerships between private and public sectors...

Just last week, we wrote about how drug development costs are keeping obesity drugs off the market. This week, we take a look at Alzheimer’s...